Impedimed

What indicators would you like to setup a trade for?

Candlestick Daily volume index Bar reversal Edit

Trade setup

Position Order Entry Exit Stop Loss Risk Return Expectancy
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

What indicators would you like to backtest?

Candlestick Daily volume index Bar reversal Edit

Backtest results

Position Trades Duration Win rate Win/loss Avg win Avg loss Return
Long 10 4.5 20% 25% 1.6% -0.8% -3.4%
Short 5 4.2 40% 67% 1.9% -3.2% -5.9%

Company

Indicator

Code Company Date Close Change Indicator Value Signal

Trading Performance

Money Flow Index

Score

-0.7

Position Trades Duration Win Rate Win/Loss Avg Win Avg Loss Return
LONG 4 24.5 0.00% 0.00% 0.0% -19.1% -76.4%
SHORT 3 203.7 0.33% 0.50% 281.6% -18.0% 245.7%

Summary

Technical Analysis

Impedimed (IPD.AX)


Indicator:

MONEY FLOW INDEX


Last Signal:

NEUTRAL


Trading: NO POSITION
Signal Strength: MEDIUM


Money Flow Index (MFI) is a volume-based indicator it could be used in technical analysis to measure the strength of money flow in and out of a security index and market. The principle of MFI calculation is a comparison of positive money flow to negative money flow. MFI is also known as volume-weighted RSI. MFI starts with the typical price for each period. The same as RSI the MFI scale is between 0 and 100.

Calculation: Money Flow Index (MFI):
1) Typical Price = (High + Low + Close)/3;
2) Raw Money Flow = Typical Price x Volume;
3) Money Flow Ratio = (14-period Positive Money Flow)/(14-period Negative Money Flow);
4) Money Flow Index = 100 - 100/(1 + Money Flow Ratio)


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Money Flow Index

Download
Company Close Change(%) Volume Value Signal
URF Us Masters Residential Property Fund 0.84 3.1 201,831 5.57 BEARISH
MOC Mortgage Choice 1.29 2.8 164,923 15.29 BEARISH
CAJ Capitol Health 0.24 2.2 83,788 17.52 BEARISH
AIA Auckland International Airport 8.62 2 48,807 6.26 BEARISH
AJM Altura Mining 0.06 1.8 1,867,922 15.02 BEARISH
MGR Mirvac 3.36 1.5 9,715,818 15.14 BEARISH
SHL Sonic Healthcare 29.16 1.5 979,728 11.48 BEARISH
ADH Adairs 2.3 0.9 1,154,750 16.44 BEARISH
SGF SG Fleet 2.68 0.8 338,167 16.14 BEARISH
HUO Huon Aquaculture 4.68 0.4 13,760 11.45 BEARISH